VISTERRA
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
VISTERRA
Social Links:
Industry:
Biotechnology Clinical Trials Health Diagnostics Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.visterrainc.com
Total Employee:
51+
Status:
Active
Contact:
6174981073
Email Addresses:
[email protected]
Total Funding:
125.39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Acumen Pharmaceuticals
Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.
Advanced Animal Diagnostics
Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
BioDetego
BioDetego is developing, VASPfore, a new biomarker test for selecting cancer treatment protocols.
Bionomics
Bionomics discovers and develops therapeutics for cancer and diseases of the central nervous system.
Brain Tunnelgenix Technologies
Brain Tunnelgenix Technologies produces non-invasive and continuous temperature measurement devices.
Broad Institute
The Broad Institute brings together a diverse group of individuals from across its partner institutions to confront biomedical challenges.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
E25Bio
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses.
Globavir
A New Approach to Treating Global Infectious Diseases
Gradalis
Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
i-Optics
i-Optics offers eye diagnosis solutions and products for age related eye diseases.
Immvira
Immvira’s scientific objectives are based on numerous experimental designs of oHSV and outcomes of clinical trials.
InnaVirVax
InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Opticul Diagnostics
Developing a multi microorganism identification device
Orgenesis
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
PhAST Diagnostics
PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Precision Biologics
Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.
ProMIS Neurosciences
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
ProteoTech
ProteoTech is a drug development company that offers therapeutics and diagnostics for amyloid diseases.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Takeda Ventures
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.
TVAX Biomedical
TVAX Biomedical develops cell-based immunotherapy for the treatment of cancer.
Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases.
Veramarx Inc.
Veramarx offers the only accurate diagnostic test for early-stage Lyme disease, which is one of the fastest growing infectious diseases.
Ziarco
Ziarco develops therapeutic agents for treating inflammatory and allergic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Flagship Pioneering
Flagship Pioneering investment in Series C - Visterra
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series C - Visterra
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Visterra
Polaris Partners
Polaris Partners investment in Series C - Visterra
Vertex Ventures HC
Vertex Ventures HC investment in Series C - Visterra
Cycad Group
Cycad Group investment in Series C - Visterra
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Visterra
Allegheny Financial Group
Allegheny Financial Group investment in Series C - Visterra
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series C - Visterra
Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. investment in Series C - Visterra
Official Site Inspections
http://www.visterrainc.com Semrush global rank: 5.12 M Semrush visits lastest month: 1.59 K
- Host name: ip-173-201-180-75.ip.secureserver.net
- IP address: 173.201.180.75
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
